Renhe Pharmacy Co.,Ltd (SHE:000650)

Renhe Pharmacy Co.,Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	522.92	2,329	2,615	2,825	2,360	1,726
Short-Term Investments	-	-	155.37	290.03	100	700
Trading Asset Securities	2,983	1,017	764.59	416.87	315.6	460.89
Cash & Short-Term Investments	3,506	3,346	3,534	3,532	2,776	2,887
Cash Growth	-0.98%	-5.34%	0.06%	27.25%	-3.83%	29.77%
Accounts Receivable	638.46	466.59	500.18	477.59	539.8	467.01
Other Receivables	17.2	6.03	8.26	8.82	10.02	6
Receivables	655.66	472.62	508.44	486.41	549.82	473.01
Inventory	395.51	486.94	446.58	457.74	601.35	465.35
Other Current Assets	439.17	514.53	94.2	104.33	128.46	63.18
Total Current Assets	4,996	4,820	4,584	4,581	4,056	3,888
Property, Plant & Equipment	1,424	1,423	1,250	1,241	1,112	751.35
Long-Term Investments	330.34	330.91	538.95	536.41	392.69	900
Goodwill	501.91	501.91	546.91	578.24	606.12	102.2
Other Intangible Assets	309.81	313.44	420.72	582.87	342.74	356.78
Long-Term Deferred Tax Assets	29.12	32.65	28.25	20.85	6.64	5.9
Long-Term Deferred Charges	15.66	14.59	16.34	22.93	310.64	311.47
Other Long-Term Assets	43.89	46.63	59.56	71.9	81.83	53.12
Total Assets	7,651	7,482	7,445	7,635	6,908	6,369
Accounts Payable	155.62	132.08	123.5	199.62	176.08	162.93
Accrued Expenses	9.18	18.99	57.81	103.52	110.71	71.89
Short-Term Debt	-	-	-	-	-	60.05
Current Portion of Long-Term Debt	0.69	0.69	-	-	-	-
Current Portion of Leases	-	-	5.79	6.72	2.84	1.66
Current Income Taxes Payable	94.51	84.14	209.63	224.76	211.59	101.42
Current Unearned Revenue	64.9	106.8	124.94	354.56	200.61	84.46
Other Current Liabilities	280.99	293.64	229.34	275.33	266.84	234.64
Total Current Liabilities	605.88	636.35	751.01	1,165	968.66	717.04
Long-Term Leases	1.91	1.89	-	5.79	3.62	2.72
Long-Term Unearned Revenue	36.38	37.96	37.11	38.83	8.25	9.39
Long-Term Deferred Tax Liabilities	0.33	0.11	1.88	3.66	0.28	0.25
Other Long-Term Liabilities	0.18	0.18	0.18	0.18	0.18	0.18
Total Liabilities	644.67	676.48	790.18	1,213	981	729.59
Common Stock	1,400	1,400	1,400	1,400	1,400	1,400
Additional Paid-In Capital	800.45	796.39	810.81	785.76	766.66	957.06
Retained Earnings	4,209	4,044	3,842	3,555	3,121	2,736
Treasury Stock	-66.96	-66.96	-60.08	-	-	-
Total Common Equity	6,342	6,174	5,993	5,741	5,287	5,093
Minority Interest	664.75	632.32	661.46	681	639.65	546.67
Shareholders' Equity	7,007	6,806	6,655	6,422	5,927	5,639
Total Liabilities & Equity	7,651	7,482	7,445	7,635	6,908	6,369
Total Debt	2.6	2.58	5.79	12.52	6.46	64.44
Net Cash (Debt)	3,503	3,343	3,529	3,520	2,770	2,822
Net Cash Growth	-0.94%	-5.26%	0.25%	27.09%	-1.86%	26.87%
Net Cash Per Share	2.51	2.40	2.55	2.51	2.00	2.24
Filing Date Shares Outstanding	1,400	1,307	1,384	1,400	1,400	1,400
Total Common Shares Outstanding	1,400	1,307	1,391	1,400	1,400	1,400
Working Capital	4,390	4,183	3,833	3,416	3,087	3,171
Book Value Per Share	4.53	4.72	4.31	4.10	3.78	3.64
Tangible Book Value	5,530	5,358	5,025	4,580	4,338	4,634
Tangible Book Value Per Share	3.95	4.10	3.61	3.27	3.10	3.31
Buildings	-	-	1,163	1,001	665.33	637.87
Machinery	-	-	539.32	549.98	513.22	463.07
Construction In Progress	-	-	345.43	409.27	580.58	233.18

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.